NCT01357876 Effect of Metformin on Gut Peptides , Bile Acids and Lipid Profiles in Type 2 Diabetics Status COMPLETED Phase PHASE1
NCT01357850 A Multi-center, Placebo-controlled Study to Evaluate the Safety of GSK716155 and Its Effects on Myocardial Metabolism, Myocardial Function, and Exercise Capacity in Patients With NYHA Class II/III Congestive Heart Failure Status COMPLETED Phase PHASE2
NCT01353768 Zanamivir Aqueous Solution Compassionate Use Program Retrospective Chart Review Study Status COMPLETED Phase N/A
NCT01353729 A Study to Evaluate the Effect of Intravenous Zanamivir on Cardiac Conduction in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01353703 Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine Status COMPLETED Phase PHASE3
NCT01352884 Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT01352312 Combination of Pentostatin, Bendamustine and Ofatumumab for Treatment of Chronic Lymphocytic Leukemia and Lymphoma Status TERMINATED Phase PHASE1
NCT01348880 Vardenafil ODT (Orally Disintegrating Tablet) - Nifedipine Interaction Study Status COMPLETED Phase PHASE1
NCT01347060 Outcomes for Medicare Asthma Patients Taking Fluticasone Propionate/Salmeterol Xinafoate Combination Versus Inhaled Corticosteroids or Other Combination Therapy Status COMPLETED Phase N/A
NCT01346852 Predictive Ability of Therapeutic Risk Factors in Pediatric and Adult Asthma Patients Status COMPLETED Phase N/A
NCT01346475 Randomized Trial to Evaluate Suppressive Effect of High-Dose Valacyclovir Versus Once-Daily Valacyclovir on Persons With HSV-2 Status COMPLETED Phase PHASE4
NCT01345266 Characterisation of Healthy Volunteers, Asthma and Chronic Obstructive Pulmonary Disease Patients for Inhalation Profile, Pharyngometry, Spirometric Indices and Lung Morphometry Status COMPLETED Phase PHASE1
NCT01345253 GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia Status COMPLETED Phase PHASE3
NCT01345240 Study to Evaluate Immunogenicity of the Hepatitis B Antigen of the GSK Biologicals' Candidate Malaria Vaccine (257049) Status COMPLETED Phase PHASE3